314 related articles for article (PubMed ID: 36361516)
1. Analyses of Transcriptomics Cell Signalling for Pre-Screening Applications in the Integrated Approach for Testing and Assessment of Non-Genotoxic Carcinogens.
Oku Y; Madia F; Lau P; Paparella M; McGovern T; Luijten M; Jacobs MN
Int J Mol Sci; 2022 Oct; 23(21):. PubMed ID: 36361516
[TBL] [Abstract][Full Text] [Related]
2. Chemical carcinogen safety testing: OECD expert group international consensus on the development of an integrated approach for the testing and assessment of chemical non-genotoxic carcinogens.
Jacobs MN; Colacci A; Corvi R; Vaccari M; Aguila MC; Corvaro M; Delrue N; Desaulniers D; Ertych N; Jacobs A; Luijten M; Madia F; Nishikawa A; Ogawa K; Ohmori K; Paparella M; Sharma AK; Vasseur P
Arch Toxicol; 2020 Aug; 94(8):2899-2923. PubMed ID: 32594184
[TBL] [Abstract][Full Text] [Related]
3. International regulatory needs for development of an IATA for non-genotoxic carcinogenic chemical substances.
Jacobs MN; Colacci A; Louekari K; Luijten M; Hakkert BC; Paparella M; Vasseur P
ALTEX; 2016; 33(4):359-392. PubMed ID: 27120445
[TBL] [Abstract][Full Text] [Related]
4. The Cell Transformation Assay: A Historical Assessment of Current Knowledge of Applications in an Integrated Approach to Testing and Assessment for Non-Genotoxic Carcinogens.
Colacci A; Corvi R; Ohmori K; Paparella M; Serra S; Da Rocha Carrico I; Vasseur P; Jacobs MN
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982734
[TBL] [Abstract][Full Text] [Related]
5. Integration of Epigenetic Mechanisms into Non-Genotoxic Carcinogenicity Hazard Assessment: Focus on DNA Methylation and Histone Modifications.
Desaulniers D; Vasseur P; Jacobs A; Aguila MC; Ertych N; Jacobs MN
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681626
[TBL] [Abstract][Full Text] [Related]
6. Increased Cell Proliferation as a Key Event in Chemical Carcinogenesis: Application in an Integrated Approach for the Testing and Assessment of Non-Genotoxic Carcinogenesis.
Strupp C; Corvaro M; Cohen SM; Corton JC; Ogawa K; Richert L; Jacobs MN
Int J Mol Sci; 2023 Aug; 24(17):. PubMed ID: 37686053
[TBL] [Abstract][Full Text] [Related]
7. Integrated approach to testing and assessment for predicting rodent genotoxic carcinogenicity.
Petkov PI; Schultz TW; Donner EM; Honma M; Morita T; Hamada S; Wakata A; Mishima M; Maniwa J; Todorov M; Kaloyanova E; Kotov S; Mekenyan OG
J Appl Toxicol; 2016 Dec; 36(12):1536-1550. PubMed ID: 27225589
[TBL] [Abstract][Full Text] [Related]
8. Assessing chemical carcinogenicity: hazard identification, classification, and risk assessment. Insight from a Toxicology Forum state-of-the-science workshop.
Felter SP; Bhat VS; Botham PA; Bussard DA; Casey W; Hayes AW; Hilton GM; Magurany KA; Sauer UG; Ohanian EV
Crit Rev Toxicol; 2021 Sep; 51(8):653-694. PubMed ID: 35239444
[TBL] [Abstract][Full Text] [Related]
9. Applicability of Scrape Loading-Dye Transfer Assay for Non-Genotoxic Carcinogen Testing.
Sovadinová I; Upham BL; Trosko JE; Babica P
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445682
[TBL] [Abstract][Full Text] [Related]
10. A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells.
Wilde EC; Chapman KE; Stannard LM; Seager AL; Brüsehafer K; Shah UK; Tonkin JA; Brown MR; Verma JR; Doherty AT; Johnson GE; Doak SH; Jenkins GJS
Arch Toxicol; 2018 Feb; 92(2):935-951. PubMed ID: 29110037
[TBL] [Abstract][Full Text] [Related]
11. A modular strategy for the testing and assessment of non-genotoxic carcinogens.
Louekari K; Jacobs MN
Arch Toxicol; 2024 May; ():. PubMed ID: 38811392
[TBL] [Abstract][Full Text] [Related]
12. In Vitro-In Vivo Carcinogenicity.
Steinberg P
Adv Biochem Eng Biotechnol; 2017; 157():81-96. PubMed ID: 27506831
[TBL] [Abstract][Full Text] [Related]
13. A feasibility study: Can information collected to classify for mutagenicity be informative in predicting carcinogenicity?
Petkov PI; Patlewicz G; Schultz TW; Honma M; Todorov M; Kotov S; Dimitrov SD; Donner EM; Mekenyan OG
Regul Toxicol Pharmacol; 2015 Jun; 72(1):17-25. PubMed ID: 25792138
[TBL] [Abstract][Full Text] [Related]
14. Gene Expression over Time during Cell Transformation Due to Non-Genotoxic Carcinogen Treatment of Bhas 42 Cells.
Ohmori K; Kamei A; Watanabe Y; Abe K
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328637
[TBL] [Abstract][Full Text] [Related]
15. The influence of chemical structure on the extent and sites of carcinogenesis for 522 rodent carcinogens and 55 different human carcinogen exposures.
Ashby J; Paton D
Mutat Res; 1993 Mar; 286(1):3-74. PubMed ID: 7678908
[TBL] [Abstract][Full Text] [Related]
16. Epigenetic events during the process of cell transformation induced by carcinogens (review).
Nguyen-Ba G; Vasseur P
Oncol Rep; 1999; 6(4):925-32. PubMed ID: 10373683
[TBL] [Abstract][Full Text] [Related]
17. The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro.
Mascolo MG; Perdichizzi S; Vaccari M; Rotondo F; Zanzi C; Grilli S; Paparella M; Jacobs MN; Colacci A
Carcinogenesis; 2018 Jul; 39(7):955-967. PubMed ID: 29554273
[TBL] [Abstract][Full Text] [Related]
18. In vivo murine hepatic microRNA and mRNA expression signatures predicting the (non-)genotoxic carcinogenic potential of chemicals.
Melis JP; Derks KW; Pronk TE; Wackers P; Schaap MM; Zwart E; van Ijcken WF; Jonker MJ; Breit TM; Pothof J; van Steeg H; Luijten M
Arch Toxicol; 2014 Apr; 88(4):1023-34. PubMed ID: 24390151
[TBL] [Abstract][Full Text] [Related]
19. Toxicogenomics - What added Value Do These Approaches Provide for Carcinogen Risk Assessment?
Schmitz-Spanke S
Environ Res; 2019 Jun; 173():157-164. PubMed ID: 30909101
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for the evaluation of chemicals for carcinogenicity. Committee on Carcinogenicity of Chemicals in Food, Consumer Products and the Environment.
Rep Health Soc Subj (Lond); 1991; 42():1-80. PubMed ID: 1763238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
